Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 5
1991 1
1995 1
1997 1
2006 3
2007 6
2008 14
2009 18
2010 30
2011 39
2012 43
2013 50
2014 51
2015 49
2016 38
2017 40
2018 39
2019 28
2020 41
2021 41
2022 26
2023 22
2024 29
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

547 results

Results by year

Filters applied: . Clear all
Page 1
Asenapine.
[No authors listed] [No authors listed] 2023 Jun 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2023 Jun 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643422 Free Books & Documents. Review.
Asenapine is a second generation (atypical) antipsychotic agent that is taken sublingually and used in the treatment of schizophrenia and manic or mixed episodes associated with bipolar 1 disorder. Asenapine is associated with a low rate of transient and mild serum …
Asenapine is a second generation (atypical) antipsychotic agent that is taken sublingually and used in the treatment of schizophrenia …
Asenapine.
[No authors listed] [No authors listed] 2025 Mar 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2025 Mar 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000744 Free Books & Documents. Review.
No information is available on the use of asenapine during breastfeeding. If asenapine is required by the mother, it is not a reason to discontinue breastfeeding. ...
No information is available on the use of asenapine during breastfeeding. If asenapine is required by the mother, it is not a …
Asenapine for the treatment of bipolar disorder.
Marazziti D, Mucci F, Falaschi V, Dell'Osso L. Marazziti D, et al. Expert Opin Pharmacother. 2019 Aug;20(11):1321-1330. doi: 10.1080/14656566.2019.1617849. Epub 2019 May 27. Expert Opin Pharmacother. 2019. PMID: 31132287 Review.
A class of drugs commonly used in this condition is second-generation antipsychotics (SGAs) including asenapine, one of the latest to be introduced into the clinical practice worldwide to treat manic episodes in BDI. ...Taken together, the published studies indicate that …
A class of drugs commonly used in this condition is second-generation antipsychotics (SGAs) including asenapine, one of the latest to …
Asenapine: Pharmacological Aspects and Role in Psychiatric Disorders.
Reyad AA, Mishriky R. Reyad AA, et al. Psychiatr Danub. 2019 Jun;31(2):157-161. doi: 10.24869/psyd.2019.157. Psychiatr Danub. 2019. PMID: 31291219 Free article. Review.
Asenapine fulfils important requirements of efficacy and tolerability as an anti-psychotic. These findings should support psychiatrists and pharmacists in the care of their patients while on asenapine....
Asenapine fulfils important requirements of efficacy and tolerability as an anti-psychotic. These findings should support psychiatris …
Asenapine for the Treatment of Psychotic Disorders.
Orr C, Deshpande S, Sawh S, Jones PM, Vasudev K. Orr C, et al. Can J Psychiatry. 2017 Feb;62(2):123-137. doi: 10.1177/0706743716661324. Epub 2016 Aug 6. Can J Psychiatry. 2017. PMID: 27481921 Free PMC article. Review.
No differences were found between asenapine and olanzapine in rates of discontinuation due to adverse drug reactions or lack of efficacy, but those taking asenapine had higher rates of withdrawal for any reason than those taking olanzapine. ...In comparison to place …
No differences were found between asenapine and olanzapine in rates of discontinuation due to adverse drug reactions or lack of effic …
Asenapine: an atypical antipsychotic with atypical formulations.
Musselman M, Faden J, Citrome L. Musselman M, et al. Ther Adv Psychopharmacol. 2021 Sep 11;11:20451253211035269. doi: 10.1177/20451253211035269. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 34540197 Free PMC article. Review.
Asenapine is a second-generation (atypical) antipsychotic medication not available in a pill that can be swallowed; rather, it is commercialized in sublingual and transdermal formulations. ...This is a narrative review of the chemistry and pharmacokinetics/pharmacodynamics …
Asenapine is a second-generation (atypical) antipsychotic medication not available in a pill that can be swallowed; rather, it is com …
Transdermal Asenapine in Schizophrenia: A Systematic Review.
Carrithers B, El-Mallakh RS. Carrithers B, et al. Patient Prefer Adherence. 2020 Aug 25;14:1541-1551. doi: 10.2147/PPA.S235104. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 32943849 Free PMC article. Review.
Recently, a transdermal formulation of asenapine has been approved for schizophrenia by the Food and Drug Administration. METHODS: A systematic review of transdermal asenapine was done utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses …
Recently, a transdermal formulation of asenapine has been approved for schizophrenia by the Food and Drug Administration. METHODS: A …
Asenapine: A Review in Schizophrenia.
Plosker GL, Deeks ED. Plosker GL, et al. CNS Drugs. 2016 Jul;30(7):655-66. doi: 10.1007/s40263-016-0363-2. CNS Drugs. 2016. PMID: 27356921 Review.
A meta-analysis of four short-term trials with asenapine (that also included a negative study and a failed trial) also showed significant benefit with asenapine over placebo. ...However, in two trials in patients with persistent negative symptoms of schizophrenia, …
A meta-analysis of four short-term trials with asenapine (that also included a negative study and a failed trial) also showed signifi …
Diagnosis and Treatment of Bipolar Disorder: A Review.
Nierenberg AA, Agustini B, Köhler-Forsberg O, Cusin C, Katz D, Sylvia LG, Peters A, Berk M. Nierenberg AA, et al. JAMA. 2023 Oct 10;330(14):1370-1380. doi: 10.1001/jama.2023.18588. JAMA. 2023. PMID: 37815563 Review.
Antipsychotic agents, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine, are recommended, but some are associated with weight gain. ...First-line therapy includes mood stabilizers, such as lithium, anticonvulsants, such as valproate and lamotrigine, …
Antipsychotic agents, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine, are recommended, but some are associa …
Asenapine Transdermal Patch for the Management of Schizophrenia.
Zhou M, Derakhshanian S, Rath A, Bertrand S, DeGraw C, Barlow R, Menard A, Kaye AM, Hasoon J, Cornett EM, Kaye AD, Viswanath O, Urits I. Zhou M, et al. Psychopharmacol Bull. 2020 Sep 14;50(4):60-82. Psychopharmacol Bull. 2020. PMID: 33012873 Free PMC article. Review.
PURPOSE OF REVIEW: This is a comprehensive review of the literature regarding the use of asenapine for the treatment of schizophrenia (SZ) in adults. It covers an introduction, epidemiology, risk factors, pathophysiology, and current treatment modalities regarding SZ, prov …
PURPOSE OF REVIEW: This is a comprehensive review of the literature regarding the use of asenapine for the treatment of schizophrenia …
547 results